On the stock market since 2015, it operates in the world of health and science. It has 1,599 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 69% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $4.4B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 31% — still a thick cushion, though costs have been eating into it lately.
Over the last 3 years, sales grew about 114% a year on average.
There is $4.4B in the vault; even if every debt were paid off, $4.4B would remain.
The company’s market value is 38 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
On our five-subject report card, ARGNF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ARGNF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.